Perrigo Company, a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products, has started shipping over-the-counter Ibuprofen and diphenhydramine citrate tablets, 200/38 mg.
 
The product will be marketed under store brand labels and is comparable to Wyeth Consumer Healthcare's Advil PM tablets, 200/38 mg, indicated as a pain reliever (NSAID)/nighttime sleep-aid. Estimated brand sales for the product for the last 12 months ending September 28, 2008 were $70 million.
 
Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products. The company’s three segments are Consumer Healthcare, Rx Pharmaceuticals and API. The company has other category that includes two operating segments: Israel Consumer Products and Israel Pharmaceutical and Diagnostic Products.
 
In the US, its operations are conducted through L Perrigo Company, Perrigo Company of South Carolina, and Perrigo New York. Outside the US, its operations are conducted through Perrigo Israel Pharmaceuticals, Chemagis, Quimica y Farmacia, Wrafton Laboratories, Perrigo UK and Galpharm Healthcare. In October 2008, the company acquired Laboratorios Diba. In November 2008, it announced that it has acquired Unico Holdings.